CTC Bio Inc
KOSDAQ:060590
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
C
|
CTC Bio Inc
KOSDAQ:060590
|
95.5B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
932.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
271B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.2B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.8B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
287.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
CTC Bio Inc
Glance View
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for CTC Bio Inc is 39.9%, which is above its 3-year median of 34.3%.
Over the last 3 years, CTC Bio Inc’s Gross Margin has increased from 31.7% to 39.9%. During this period, it reached a low of 31.2% on Mar 31, 2023 and a high of 39.9% on Sep 30, 2025.
